G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2004
12/28/2004	US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/28/2004	US6835549 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma
12/28/2004	US6835547 Methods for identifying modulators of CCX CKR activity
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835545 Methods, products and treatments for diabetes
12/28/2004	US6835543 Step agglutination immunoassay
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	US6835351 Linear chain hydrophile polymer carrying a luminescence indicator of a non-lipophile (bis)acridine compound; determination of the concentration of chloride
12/28/2004	US6835350 For qualitative and/or quantitative analysis for one or more substances by an optical means
12/28/2004	US6834553 Proof testing capstans for reducing shear and fiber coating deformation
12/28/2004	US6834550 Soil profile force measurement using an instrumented tine
12/28/2004	US6834536 Probe for measuring alcohol in liquids
12/28/2004	US6834530 Odor measuring apparatus
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/26/2004	CA2470966A1 Pharmacophore model generation and use
12/26/2004	CA2430835A1 Methods for making and breaking prions (prpsc) produced from native prions (prpc), in vitro and from recombinant prion proteins
12/23/2004	WO2004111914A2 Efficient methods for multibody simulations
12/23/2004	WO2004111884A1 Method of identifying/designing and/or modifying chemical species capable of interacting with a physiologically active macromolecule
12/23/2004	WO2004111832A1 Improved method for diagnosing and treating breast cancer
12/23/2004	WO2004111663A2 System for generating and using biological qualification slides to qualify biological screening devices
12/23/2004	WO2004111656A1 Coagulation tests at ambient temperature
12/23/2004	WO2004111655A1 Systems and methods for characterization of molecules
12/23/2004	WO2004111654A2 Serum biomarkers in ischaemic heart disease
12/23/2004	WO2004111653A1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/23/2004	WO2004111652A1 Use of prion conversion modulating agents
12/23/2004	WO2004111651A1 Method for laboratory-medical diagnosis of cerebrospinal fluid of an intrathecal immunoglobulin synthesis by measuring the free kappa immunoglobulin light chains
12/23/2004	WO2004111650A1 Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer
12/23/2004	WO2004111649A1 Method for measuring substance having affinity
12/23/2004	WO2004111648A2 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules
12/23/2004	WO2004111647A1 Analysis of a microarray data set
12/23/2004	WO2004111646A1 Novel ms reagents
12/23/2004	WO2004111645A1 Method of adjudicating on acute aortic dissection and reagent for adjudication
12/23/2004	WO2004111644A1 Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method
12/23/2004	WO2004111643A2 Patterns for a skeletal system
12/23/2004	WO2004111642A2 Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 1 (snsr1)
12/23/2004	WO2004111641A2 Methods for detecting cancer and monitoring cancer progression
12/23/2004	WO2004111640A1 Quantitative method and quantitative chip for objective substance
12/23/2004	WO2004111638A1 Liquid permeable composition in dry reagent devices
12/23/2004	WO2004111637A2 Dendritic cells for prognosis of metastatic evolution of tumors
12/23/2004	WO2004111636A2 Peptide combos and their uses
12/23/2004	WO2004111627A1 Automobile gas detector
12/23/2004	WO2004111626A1 A mass amplified piezoelectric biochip
12/23/2004	WO2004111620A1 Bioassay substrate and bioassay device and method
12/23/2004	WO2004111619A1 Impurity measuring method and device
12/23/2004	WO2004111616A1 Device and method for identifying types of sheet materials
12/23/2004	WO2004111615A1 Concrete sample body-forming frame
12/23/2004	WO2004111613A2 Fluid sampling components
12/23/2004	WO2004111612A2 Porous nanostructures and methods involving the same
12/23/2004	WO2004111610A2 Method and system for the analysis of high density cells samples
12/23/2004	WO2004111608A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/23/2004	WO2004111601A2 Couette device and method to study solids deposition from flowing fluids
12/23/2004	WO2004111264A1 Bacterial biofilm assay employing magnetic beads
12/23/2004	WO2004111262A1 Method of identifying a selective chemotherapeutic agent
12/23/2004	WO2004111259A2 Hydrolytic substrates for an analyte-dependent enzyme activation system
12/23/2004	WO2004111227A2 Screening process for hydantoin racemases
12/23/2004	WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
12/23/2004	WO2004111209A1 Monitoring method using micromembrane probes
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111192A2 Targeted delivery to legumain-expressing cells
12/23/2004	WO2004111186A2 Monitoring for and detecting microbes used in bioterrorism
12/23/2004	WO2004111180A2 Methods and compositions for selectively enriching microbes
12/23/2004	WO2004111087A2 Chemokin-binding protein thap1, methods and use thereof
12/23/2004	WO2004111081A2 Antigenic peptides of sars coronavirus and uses thereof
12/23/2004	WO2004111080A1 Epitopes of the cytomegalovirus pp65 protein
12/23/2004	WO2004110963A2 Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
12/23/2004	WO2004110676A1 A method and a device for detecting slag
12/23/2004	WO2004110675A1 A method and a device for detecting slag
12/23/2004	WO2004110647A2 Microfluidic water analytical device
12/23/2004	WO2004110416A2 Use of a cx3c agonist for the treatment of pain and for promoting nerve regeneration
12/23/2004	WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004	WO2004110384A2 Hiv-1 envelope glycoproteins having unusual disulfide structure
12/23/2004	WO2004110370A2 Etiologic agnet for sow infertility syndrome
12/23/2004	WO2004110369A2 Cell surface protein associated with human chronic lymphocytic leukemia
12/23/2004	WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/23/2004	WO2004110356A2 Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity
12/23/2004	WO2004110345A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
12/23/2004	WO2004110256A2 Glucose measuring module and insulin pump combination
12/23/2004	WO2004110250A2 Diagnostic method for atherosclerosis
12/23/2004	WO2004110246A2 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns
12/23/2004	WO2004110243A2 COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPsc
12/23/2004	WO2004110138A1 Model mouse
12/23/2004	WO2004097429A3 Apociii and the treatmentand diagnosis of diabetes
12/23/2004	WO2004097051A3 Methods for diagnosing aml and mds differential gene expression
12/23/2004	WO2004094673A8 Methods for monitoring drug activities in vivo
12/23/2004	WO2004094465A8 Synthetic molecules that mimic chemokines
12/23/2004	WO2004092354A3 Ex vivo skin organ model, especially for human skin
12/23/2004	WO2004090539A3 Methods of determining efficacy of treatments of inflammatory diseases of the bowel
12/23/2004	WO2004089182A3 Anti-retroviral analysis by mass spectrometry
12/23/2004	WO2004084943A8 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
12/23/2004	WO2004083366A3 Methods utilizing novel target genes related to immune-mediated diseases
12/23/2004	WO2004082571A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86)
12/23/2004	WO2004080416A3 Animal model simulating neurologic disease
12/23/2004	WO2004080270A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
12/23/2004	WO2004076684A3 Compositions and methods for the detection of mammalian muscle troponin i
12/23/2004	WO2004075021A3 Molecular modeling methods
12/23/2004	WO2004074310A8 Mycobacterial diagnostics
12/23/2004	WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using
12/23/2004	WO2004071179A3 Method of assaying for high performance mammals
12/23/2004	WO2004064594A3 Biochemical predictor test for obstetric cholestasis
12/23/2004	WO2004055169A3 Cytochrome c acetylation

1 ... 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 ... 3937